Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Articles
DOI: 10.1055/s-0040-1705653
Submitted: 02-23-2022
Published: 02-23-2022

O que podemos fazer para evitar as doenças inflamatórias intestinais? A importância da microbiota

Gastroenterologista pediátrica do Hospital Israelita Albert Einstein e do Hospital Municipal Menino Jesus – SP / Assistente colaboradora do Ambulatório de Doenças Intestinais do HCFMUSP
Crohn’s Disease Ulcerative Colitis microbiota

Abstract

Inflammatory bowel disease (IBD) are characterized by chronic,recurrent and idiopathic inflammation, which result from an inappropriate immune response in genetically susceptible individuals. Essentially IBD comprises two forms of presentation: ulcerative colitis (UC) and Crohn’s disease (CD). The UCaffects the mucosa of colon and rectum and, classically, has symmetrical distribution, ascendingand continuous. The DC is characterized by a chronic transmural inflammation of the digestivetract, which can affect the mouth to the anus segmentally or sauteed, with frequent involvementof the ileal or ileocecal region. The disease pathogenesis is not fully understood, it appear to be triggered by the mutual interaction of environmental, immune, genes and microbiota. In recent years several studies were published on the changes of microbiota in these patients demonstrating the importance of this factor. The knowledgement of environmental risk factors supports international planning to the use resources for health, scientific researches and may be a potential therapeutic target, as was stated in the last ESPGHAN 2016.

Metrics

Metrics Loading ...

References

  1. Abraham C, Cho JH. Inflammatoryboweldisease. N Engl J Med 2009;361:2066-78.
  2. Ordás I, Eckmann L, Talamini M et al. Ulcerativecolitis. Lancet 2012;380:1606-19.
  3. Baumgart DC, Sandborn WJ. Crohn’sdisease. Lancet 2012;380:1590-605.
  4. Gensollen T, Iyer SS, Kasper DLet al. Howcolonizationby microbiota in earlylifeshapestheimmune system. Science 2016;352:539-44.
  5. Rautava S, Luoto R, Salminen S et al. Microbial contactduringpregnancy, intestinal colonizationandhumandisease. Nat RevGastroenterolHepatol 2012;9:565-76.
  6. Blaser MJ. Antibiotic use and its consequences forthe normal microbiome. Science 2016;352:544-5.
  7. Biagi E, Nylund L, Candela M et al. Throughageing, and beyond: gut microbiota andinflammatory status in seniorsandcentenarians. PLoSOne 2010;5:e10667.
  8. Houghteling PD, Walker WA. Why is initial bacterial colonization of the intestine important to infants’ and children’s health? J PediatrGastroenterolNutr 2015; 60:294-307.
  9. Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 2011;473:174-80.
  10. Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105-8.
  11. Garrett WS, Gordon JI, Glimcher LH. Homeostasisandin-flammation in the intestine. Cell 2010;140:859-70.
  12. Geremia A, Biancheri P, Allan P et al. Innateandadaptiveimmunity in inflammatoryboweldisease. AutoimmunRev 2014;13:3-10.
  13. Van Lierop PP, Samsom JN, Escher JC et al. Role oftheinnateimmune system in the pathogenesis of inflammatory bowel disease. J PediatrGastroenterolNutr 2009;48:142-51.
  14. Hoebe K, Janssen E, Beutler B. The interface betweeninnateandadaptiveimmunity. Nat Immunol 2004;5:971-4.
  15. Manichanh C, Borruel N, Casellas F et al. The gut microbiota in IBD. Nat RevGastroenterolHepatol 2012;9:599-608.
  16. Rajca S,Grondin V, Louis E et al. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’sdisease. InflammBowelDis 2014;20:978-86.
  17. Benchimol EI, Manuel DG, To T et al. Asthma, type 1 and type 2 diabetes mellitus, and inflammatory bowel disease among st South Asianimmigrantsto Canada andtheirchildren: a population-based cohortstudy. PLoSOne 2015;10:e0123599.
  18. Chu H, Khosravi A, Kusumawardhani IP et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 2016;27;352:1116-20.
  19. Uhlig HH, Schwerd T, Koletzko S et al. in IBD StudyGroupand NEOPICS. The diagnostic approach tomonogenic very early on set inflammatory bowel disease. Gastroenterology 2014;147:990-1007.

How to Cite

Oba, J. (2022). O que podemos fazer para evitar as doenças inflamatórias intestinais? A importância da microbiota. International Journal of Nutrology, 10(1), 306–312. https://doi.org/10.1055/s-0040-1705653